<DOC>
	<DOCNO>NCT00788034</DOCNO>
	<brief_summary>The study evaluate long-term maintenance efficacy Lu AA21004 patient Generalized Anxiety Disorder ( GAD ) respond acute treatment Lu AA21004 .</brief_summary>
	<brief_title>Relapse-prevention Study With Lu AA21004 ( Vortioxetine ) Patients With Generalized Anxiety Disorder</brief_title>
	<detailed_description>GAD common disable mental disorder associate substantial medical psychiatric comorbidity occupational impairment . It characterize inappropriate excessive anxiety worry persists time six month . Common feature include apprehension , worry future misfortune ; inner tension difficulty concentrating ; motor tension , restlessness , tremor headache ; autonomic anxiety symptom , excessive perspiration , dry mouth epigastric discomfort . GAD typically chronic disorder high relapse rate therefore require effective long-term treatment . Long-term study necessary demonstrate short-term effect maintain .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>The patient GAD primary diagnosis accord DSMIVTR criterion ( classification code 300.02 ) . The patient HAMA total score &gt; =20 screen baseline visit The patient HAMA score &gt; =2 Item 1 ( anxious mood ) Item 2 ( tension ) screen baseline visit The patient MADRS total score &lt; =16 screen baseline visit Any current psychiatric disorder GAD define DSMIVTR ( assess MINI ) Any substance disorder ( except nicotine caffeine ) within previous 6 month define DSMIVTR Women childbearing potential use effective contraception Other protocoldefined inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Relapse prevention</keyword>
	<keyword>GAD</keyword>
	<keyword>Maintenance</keyword>
	<keyword>Double-blind</keyword>
	<keyword>Multicentre</keyword>
</DOC>